Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Remuneration Information 2021

Apr 9, 2021

6990_rns_2021-04-09_14abcd80-6478-4394-8a09-4a9d2b934616.htm

Remuneration Information

Open in viewer

Opens in your device viewer

_________ false

�������� ��������� ���� 2 381
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001 8544
- - -
Israel Securities Authority Tel Aviv Stock Exchange C003 ( Public ) Reported via MAGNA: 09/04/2021
www.isa.gov.il www.tase.co.il Reference: 2021-02-060630 Time of broadcast: 17:31 17:31

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on _________

ea139144-def14a_pluristemEDGAR1_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 03/03/2021
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected]   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Aberman Zalman Position of Signatory in the reporting corporation: Chairman Of The Board & CEO Name of Employer Company:
Address: Matam Park 20 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7107172 E-mail: [email protected] 2